What is a stock summary page? Click here for an overview.
Business Description
Seoul Pharma Co Ltd
ISIN : KR7018680009
Compare
Compare
Traded in other countries / regions
018680.Korea Index Membership
KOSDAQ Composite Index IPO Date
2000-08-18Description
Seoul Pharma Co Ltd is engaged in manufacturing and distribution of pharmaceuticals products in South Korea. Its products portfolio consists of drugs for the cardiovascular system, respiratory system, and digestive system, drugs for hypertension, antipyretics, drugs for skin disease, drugs for a cough as well as ointments, among others.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.47 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.4 | |||||
| Debt-to-EBITDA | 3.44 | |||||
| Interest Coverage | 5.22 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.99 | |||||
| Beneish M-Score | -1.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1 | |||||
| 3-Year FCF Growth Rate | -10.5 | |||||
| 3-Year Book Growth Rate | 15.7 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 76.32 | |||||
| 9-Day RSI | 68.8 | |||||
| 14-Day RSI | 62.6 | |||||
| 3-1 Month Momentum % | -6.35 | |||||
| 6-1 Month Momentum % | -18.88 | |||||
| 12-1 Month Momentum % | -1.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.28 | |||||
| Quick Ratio | 1.43 | |||||
| Cash Ratio | 0.53 | |||||
| Days Inventory | 208.45 | |||||
| Days Sales Outstanding | 39.88 | |||||
| Days Payable | 49.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11 | |||||
| Shareholder Yield % | -5.5 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.46 | |||||
| Operating Margin % | 2.85 | |||||
| Net Margin % | 3.17 | |||||
| FCF Margin % | -9.78 | |||||
| ROE % | 4.31 | |||||
| ROA % | 2.54 | |||||
| ROIC % | 2.61 | |||||
| 3-Year ROIIC % | -233.12 | |||||
| ROC (Joel Greenblatt) % | 5.33 | |||||
| ROCE % | 4.29 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.08 | |||||
| PE Ratio without NRI | 23.08 | |||||
| PS Ratio | 0.73 | |||||
| PB Ratio | 0.98 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | 21.74 | |||||
| EV-to-EBITDA | 10.2 | |||||
| EV-to-Revenue | 0.89 | |||||
| EV-to-FCF | -9.14 | |||||
| Price-to-GF-Value | 0.9 | |||||
| Price-to-Projected-FCF | 1.06 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Price-to-Graham-Number | 1.01 | |||||
| Price-to-Net-Current-Asset-Value | 48.57 | |||||
| Earnings Yield (Greenblatt) % | 4.6 | |||||
| FCF Yield % | -13.33 | |||||
| Forward Rate of Return (Yacktman) % | -60.89 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Seoul Pharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 53,579.628 | ||
| EPS (TTM) (â‚©) | 146 | ||
| Beta | 0.72 | ||
| 3-Year Sharpe Ratio | -0.79 | ||
| 3-Year Sortino Ratio | -0.99 | ||
| Volatility % | 31.16 | ||
| 14-Day RSI | 62.6 | ||
| 14-Day ATR (â‚©) | 91.487125 | ||
| 20-Day SMA (â‚©) | 3185.5 | ||
| 12-1 Month Momentum % | -1.67 | ||
| 52-Week Range (â‚©) | 2970 - 6350 | ||
| Shares Outstanding (Mil) | 11.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Seoul Pharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Seoul Pharma Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Seoul Pharma Co Ltd Frequently Asked Questions
What is Seoul Pharma Co Ltd(XKRX:018680)'s stock price today?
The current price of XKRX:018680 is â‚©3370.00. The 52 week high of XKRX:018680 is â‚©6350.00 and 52 week low is â‚©2970.00.
When is next earnings date of Seoul Pharma Co Ltd(XKRX:018680)?
The next earnings date of Seoul Pharma Co Ltd(XKRX:018680) is .
Does Seoul Pharma Co Ltd(XKRX:018680) pay dividends? If so, how much?
Seoul Pharma Co Ltd(XKRX:018680) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers